Two-Phase Synthesis of Taxol

Taxol (a brand name for paclitaxel) is widely regarded as among the most famed natural isolates ever discovered, and has been the subject of innumerable studies in both basic and applied science. Its documented success as an anticancer agent, coupled with early concerns over supply, stimulated a fur...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Chemical Society Vol. 142; no. 23; pp. 10526 - 10533
Main Authors Kanda, Yuzuru, Nakamura, Hugh, Umemiya, Shigenobu, Puthukanoori, Ravi Kumar, Appala, Venkata Ramana Murthy, Gaddamanugu, Gopi Krishna, Paraselli, Bheema Rao, Baran, Phil S.
Format Journal Article
LanguageEnglish
Published WASHINGTON Amer Chemical Soc 10.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Taxol (a brand name for paclitaxel) is widely regarded as among the most famed natural isolates ever discovered, and has been the subject of innumerable studies in both basic and applied science. Its documented success as an anticancer agent, coupled with early concerns over supply, stimulated a furious worldwide effort from chemists to provide a solution for its preparation through total synthesis. Those pioneering studies proved the feasibility of retrosynthetically guided access to synthetic Taxol, albeit in minute quantities and with enormous effort. In practice, all medicinal chemistry efforts and eventual commercialization have relied upon natural (plant material) or biosynthetically derived (synthetic biology) supplies. Here we show how a complementary divergent synthetic approach that is holistically patterned off of biosynthetic machinery for terpene synthesis can be used to arrive at Taxol.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-7863
1520-5126
1520-5126
DOI:10.1021/jacs.0c03592